| scholarly article | Q13442814 |
| P50 | author | Daisuke Takahari | Q87662858 |
| Narikazu Boku | Q88572199 | ||
| P2093 | author name string | Hiroyuki Arai | |
| Hirofumi Yasui | |||
| Keiko Minashi | |||
| Takako Eguchi Nakajima | |||
| Satoru Iwasa | |||
| Kei Muro | |||
| Shuichi Hironaka | |||
| Toshiki Masuishi | |||
| Naoki Fukuda | |||
| Masahiro Kawahira | |||
| P2860 | cites work | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 |
| Regional but fatal: Intraperitoneal metastasis in gastric cancer | Q28067269 | ||
| Capecitabine and oxaliplatin for advanced esophagogastric cancer. | Q33313072 | ||
| Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer | Q33488159 | ||
| Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer | Q34366342 | ||
| S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial | Q34588472 | ||
| Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study | Q43264239 | ||
| Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106). | Q46350650 | ||
| First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake | Q48177237 | ||
| FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis | Q49540586 | ||
| Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis | Q57918124 | ||
| Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing r | Q64109947 | ||
| A new scoring system for peritoneal metastasis in gastric cancer | Q79103223 | ||
| First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer | Q84107291 | ||
| Multicenter feasibility study of combination therapy with fluorouracil, leucovorin and paclitaxel (FLTAX) for peritoneal disseminated gastric cancer with massive ascites or inadequate oral intake | Q84562240 | ||
| Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer | Q85790104 | ||
| Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial | Q88626522 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 652 | |
| P577 | publication date | 2019-07-03 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study | |
| P478 | volume | 19 |
Search more.